2024
Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review
Panicker A, Prokop L, Hacke K, Jaramillo A, Griffiths L. Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review. The Journal Of Heart And Lung Transplantation 2024, 43: 1450-1467. PMID: 38796046, DOI: 10.1016/j.healun.2024.05.012.Peer-Reviewed Original ResearchConceptsNon-HLA antibodiesEndomyocardial biopsyHeart transplantationRejection pathologyDonor-specific anti-human leukocyte antigen antibodiesAnti-human leukocyte antigen antibodiesHistocompatibility complex class I chain-related gene ANon-human leukocyte antigenSystematic reviewNon-HLA antigensStrength of evidenceAntibody-mediated rejectionInvasive endomyocardial biopsyPositive endomyocardial biopsyClinical risk stratificationHLA-DSAHT recipientsRejection monitoringLeukocyte antigenRisk stratificationRejection eventsRisk factorsInclusion criteriaAntigen antibodiesAntibodies
2020
Role of non-HLA antigens in cardiac transplant rejection
Panicker A, Gates K, Biendarra-Tiegs S, Vetr N, Higuita M, Nelson T, Pereira N, Griffiths L. Role of non-HLA antigens in cardiac transplant rejection. The Journal Of Immunology 2020, 204: 161.7-161.7. DOI: 10.4049/jimmunol.204.supp.161.7.Peer-Reviewed Original ResearchNon-HLA antigensNon-HLA antibodiesHeart transplant patientsHuman leukocyte antigenImmune responseTransplant patientsTransplant rejectionDonor-specific anti-HLA antibodiesTerm survivalNon-HLA antibody responsesSpecific anti-HLA antibodiesAnti-HLA antibodiesCardiac allograft vasculopathyHeart transplant recipientsCardiac transplant rejectionHeart transplant rejectionCell mediated rejectionAdaptive immune responsesLong-term survivalShort-term survivalAllograft vasculopathyRejection incidenceAcute rejectionTransplant recipientsAntigen expression